Cases 1 - 10 of 141
GlaxoSmithKline Biologicals SA et al v. Pfizer Inc. et al
as 1:2024cv00512
Plaintiff:
GlaxoSmithKline Biologicals SA and GlaxoSmithKline LLC
Defendant:
Pfizer Inc., Pharmacia & Upjohn Co. LLC, BioNTech SE and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GlaxoSmithKline Biologicals SA et al v. Pfizer Inc.
as 1:2023cv00831
Plaintiff:
GlaxoSmithKline Biologicals SA and GlaxoSmithKline LLC
Defendant:
Pfizer Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al
as 1:2023cv00578
Plaintiff:
Alnylam Pharmaceuticals, Inc.
Defendant:
Pfizer Inc. and Pharmacia & Upjohn Co. LLC
Counter Claimant:
BioNTech SE and BioNTech Manufacturing GmbH
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bristol-Myers Squibb Company et al v. Biocon Pharma Limited
as 1:2023cv00392
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
Biocon Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bristol-Myers Squibb Company et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv00393
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al
as 1:2022cv00924
Plaintiff:
Alnylam Pharmaceuticals, Inc.
Defendant:
Pfizer Inc., Pharmacia & Upjohn Co. LLC, BioNTech SE and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc., et al
as 1:2022cv00336
Plaintiff:
Alnylam Pharmaceuticals, Inc.
Defendant:
Pfizer Inc. and Pharmacia & Upjohn Co. LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Puma Biotechnology, Inc. v. AstraZeneca Pharmaceuticals LP et al
as 1:2021cv01338
Plaintiff:
Puma Biotechnology, Inc. and Wyeth LLC
Defendant:
AstraZeneca Pharmaceuticals LP, AstraZeneca AB and AstraZeneca PLC
Counter Defendant:
Pfizer Inc.
Cause Of Action: 35 U.S.C. § 1
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv00839
Counter Defendant:
Warner-Lambert Company LLC, Pfizer Inc and PF Prism IMB B.V.
Counter Claimant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. et al v. Hospira, Inc. et al
as 1:2020cv00561
Plaintiff:
Amgen Manufacturing, Limited and Amgen Inc.
Defendant:
Hospira, Inc. and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
